Financial Ratios

ABBOTT INDIA LTD.

NSE : ABBOTINDIABSE : 500488ISIN CODE : INE358A01014Industry : Pharmaceuticals & DrugsHouse : Abbott India - MNC
BSE26946.00197.55 (+0.74 %)
PREV CLOSE ( ) 26748.45
OPEN PRICE ( ) 26771.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 555
TODAY'S LOW / HIGH ( )26663.35 27200.00
52 WK LOW / HIGH ( )20594.25 29628.15
NSE27120.80409.75 (+1.53 %)
PREV CLOSE( ) 26711.05
OPEN PRICE ( ) 26858.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 33995
TODAY'S LOW / HIGH( ) 26715.00 27229.90
52 WK LOW / HIGH ( )20605.05 29638.95
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)446.78375.86325.03279.03211.93
   CEPS(Rs)479.71406.96352.39307.08219.89
   DPS(Rs)325.00275.00275.00250.0065.00
   Book NAV/Share(Rs)1480.481306.181203.711127.50932.19
   Tax Rate(%)25.4726.0325.4126.1335.56
Margin Ratios
   Core EBITDA Margin(%)21.9621.5120.5618.4716.42
   EBIT Margin(%)23.5021.8621.1219.8219.06
   Pre Tax Margin(%)23.2021.4820.7119.6119.00
   PAT Margin (%)17.2915.8915.4514.4912.24
   Cash Profit Margin (%)18.5717.2016.7515.9412.70
Performance Ratios
   ROA(%)21.7119.8918.7818.3616.90
   ROE(%)32.0729.9527.8927.0924.66
   ROCE(%)42.9340.5337.5236.5437.88
   Asset Turnover(x)1.261.251.221.271.38
   Sales/Fixed Asset(x)12.4613.1213.0416.0725.48
   Working Capital/Sales(x)3.021.901.821.771.93
Efficiency Ratios
   Fixed Capital/Sales(x)0.080.080.080.060.04
   Receivable days20.1219.5423.1926.4926.77
   Inventory Days44.4451.0250.8250.5659.14
   Payable days109.28113.47108.42104.1399.97
Valuation Parameters
   PER(x)49.4347.0946.1155.3934.43
   PCE(x)46.0443.4942.5350.3333.18
   Price/Book(x)14.9213.5512.4513.717.83
   Yield(%)1.471.551.831.620.89
   EV/Net Sales(x)8.417.106.837.493.76
   EV/Core EBITDA(x)33.0929.9329.3735.1919.25
   EV/EBIT(x)34.8931.7331.1837.7819.71
   EV/CE(x)9.918.297.708.684.72
   M Cap / Sales8.777.657.398.024.21
Growth Ratio
   Net Sales Growth(%)8.8614.005.3011.2711.52
   Core EBITDA Growth(%)16.7316.2215.1021.2811.93
   EBIT Growth(%)17.3816.3716.3915.7112.12
   PAT Growth(%)18.8715.6416.4931.6712.24
   EPS Growth(%)18.8715.6416.4931.6612.24
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)2.513.203.383.603.22
   Quick Ratio(x)1.972.632.693.002.51
   Interest Cover(x)80.6657.5351.6595.10311.82
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.